Clinical Trials

NCT00940420 | COMPLETED | PHASE4

2695 participants

A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2002-10-31

Completion:

2009-11-30

Conditions

• Hepatitis C, Chronic

Interventions

• DRUG

No Results Yet

NCT00940303 | COMPLETED | PHASE2

97 participants

OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-06-30

Completion:

2014-02-28

Conditions

• Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT00933972 | COMPLETED | PHASE1

36 participants

A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-06-30

Completion:

2010-09-30

Conditions

• Diabetes Mellitus Type 2

Interventions

• DRUG

No Results Yet

NCT00930514 | COMPLETED | PHASE1

281 participants

A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-09-30

Completion:

2013-07-31

Conditions

• Lymphoma, Follicular

Interventions

• DRUG

No Results Yet

NCT00928330 | COMPLETED | PHASE1

57 participants

Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-07-31

Completion:

2014-01-31

Conditions

• Metastatic Breast Cancer

Interventions

• DRUG

No Results Yet

NCT00922610 | COMPLETED | PHASE4

28 participants

A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-02-28

Completion:

2010-07-31

Conditions

• Anemia

Interventions

• DRUG

No Results Yet

NCT00909597 | COMPLETED | PHASE3

756 participants

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-05-31

Completion:

2010-11-30

Conditions

• Diabetes Mellitus Type 2

Interventions

• DRUG

No Results Yet

NCT00884507 | COMPLETED | PHASE2

389 participants

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-05-31

Completion:

2010-11-30

Conditions

• Alzheimer's Disease

Interventions

• DRUG

No Results Yet

NCT00882674 | COMPLETED | PHASE1

8 participants

A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-07-31

Completion:

2010-12-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT00879203 | COMPLETED

230 participants

Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)

Study Type:

OBSERVATIONAL

Last Updated:

2016-11-02

Start Date:

2008-11-30

Completion:

2013-11-30

Conditions

• Type 1 Diabetes Mellitis
• Cognition

No Results Yet

NCT00876122 | COMPLETED | PHASE1

60 participants

A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-03-31

Completion:

2012-06-30

Conditions

• Non-Hodgkin's Lymphoma, Solid Cancers

Interventions

• DRUG

No Results Yet

NCT00876109 | COMPLETED | PHASE1

108 participants

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2007-10-31

Completion:

2012-06-30

Conditions

• Solid Cancers

Interventions

• DRUG

No Results Yet

NCT00873756 | COMPLETED | PHASE1

23 participants

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-05-31

Completion:

2014-03-31

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG

No Results Yet

NCT00869661 | COMPLETED | PHASE2

413 participants

A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2001-02-28

Completion:

2012-02-29

Conditions

• Hepatitis C, Chronic

Interventions

• DRUG

No Results Yet

NCT00869089 | COMPLETED | PHASE2

5 participants

Safety and Efficacy of CC-10004 for Prurigo Nodularis

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-09-30

Completion:

2011-01-31

Conditions

• Prurigo Nodularis

Interventions

• DRUG

Results Available

NCT00854152 | COMPLETED | PHASE1

121 participants

A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-03-31

Completion:

2014-11-30

Conditions

• Non-Hodgkin's Lymphoma, Solid Cancers

Interventions

• DRUG

No Results Yet

NCT00854126 | COMPLETED | PHASE1

38 participants

A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-05-31

Completion:

2012-07-31

Conditions

• Non-Hodgkin's Lymphoma, Solid Cancers

Interventions

• DRUG

No Results Yet

NCT00845910 | TERMINATED | PHASE2

22 participants

A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-05-31

Completion:

2011-05-31

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT00842582 | WITHDRAWN | PHASE1

0 participants

Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-02-28

Completion:

2011-03-31

Conditions

• Ovarian Cancer

Interventions

• DRUG

No Results Yet

NCT00811993 | TERMINATED | PHASE1

104 participants

A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-02-28

Completion:

2012-12-31

Conditions

• Neoplasms

Interventions

• DRUG

No Results Yet

NCT00811460 | COMPLETED | PHASE1

18 participants

A Study of Taspoglutide in Type 2 Diabetic Patients

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-11-30

Completion:

2009-08-31

Conditions

• Diabetes Mellitus Type 2

Interventions

• DRUG

No Results Yet

NCT00809705 | COMPLETED | PHASE3

60 participants

A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-12-31

Completion:

2009-10-31

Conditions

• Diabetes Mellitus Type 2

Interventions

• DRUG

No Results Yet

NCT00809562 | COMPLETED | PHASE2

46 participants

A Study of RO4917523 in Patients With Treatment Resistant Depression

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-03-31

Completion:

2011-02-28

Conditions

• Depression

Interventions

• DRUG

No Results Yet

NCT00806923 | COMPLETED | PHASE3

1044 participants

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2005-02-28

Completion:

2011-02-28

Conditions

• Non-Squamous Non-Small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT00801255 | COMPLETED | PHASE1

88 participants

A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-11-30

Completion:

2010-03-31

Conditions

• Hepatitis C, Chronic

Interventions

• DRUG

No Results Yet

NCT00791557 | COMPLETED | NA

2 participants

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-10-31

Completion:

2009-12-31

Conditions

• Pyoderma Gangrenosum
• Crohn's Disease
• Ulcerative Colitis
• Inflammatory Bowel Disease

Interventions

• DRUG

Results Available

NCT00778102 | COMPLETED | PHASE2

80 participants

A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-10-31

Completion:

2013-10-31

Conditions

• Colorectal Cancer

Interventions

• DRUG

Results Available

NCT00776698 | COMPLETED | PHASE1

1 participants

A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-04-30

Completion:

2010-02-28

Conditions

• Non-Squamous Non-Small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT00774995 | COMPLETED | PHASE4

49 participants

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-11-30

Completion:

2010-06-30

Conditions

• Hepatitis B

Interventions

• BIOLOGICAL

Results Available

NCT00774241 | WITHDRAWN | PHASE4

0 participants

PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2010-01-31

Completion:

2013-11-30

Conditions

• Breast Cancer

Interventions

• DRUG

No Results Yet

NCT00773526 | COMPLETED | PHASE1

52 participants

A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-11-30

Completion:

2011-09-30

Conditions

• Neoplasms

Interventions

• DRUG

No Results Yet

NCT00773331 | COMPLETED | PHASE3

281 participants

A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2009-07-31

Completion:

2010-12-31

Conditions

• Anemia

Interventions

• DRUG

No Results Yet

NCT00773188 | COMPLETED | PHASE1

6 participants

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-12-31

Completion:

2010-10-31

Conditions

• Non-Squamous Non-Small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT00760565 | COMPLETED | PHASE1

72 participants

A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-09-30

Completion:

2011-06-30

Conditions

• Peripheral Arterial Disease (PAD)

Interventions

• DRUG

No Results Yet

NCT00723463 | COMPLETED | EARLY_PHASE1

200 participants

Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2006-06-30

Completion:

2016-06-30

Conditions

• Brain Cancer
• Neck Cancer

Interventions

• PROCEDURE

No Results Yet

NCT00721266 | COMPLETED | PHASE1

102 participants

A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-06-30

Completion:

2011-06-30

Conditions

• Neoplasms

Interventions

• DRUG

No Results Yet

NCT00717457 | COMPLETED | PHASE3

1189 participants

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-07-31

Completion:

2011-03-31

Conditions

• Diabetes Mellitus Type 2

Interventions

• DRUG

No Results Yet

NCT00700570 | COMPLETED | PHASE2

45 participants

A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-08-31

Completion:

2011-11-30

Conditions

• Colorectal Cancer

Interventions

• DRUG

Results Available

NCT00694980 | COMPLETED | PHASE1

48 participants

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-09-30

Completion:

2011-09-30

Conditions

• Ulcerative Colitis

Interventions

• DRUG

No Results Yet

NCT00682097 | COMPLETED | PHASE1

55 participants

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

Study Type:

INTERVENTIONAL

Last Updated:

2016-11-02

Start Date:

2008-05-31

Completion:

2009-03-31

Conditions

• Diabetes Mellitus Type 2

Interventions

• DRUG

No Results Yet